Page 5 - Pharmaceutical Firms

Vaccine majors see sharp rally with some players rising more than 4,000%

The Indian pharmaceutical sector has also been going through a surge

India scaling up production of active pharmaceutical ingredients: Kant

India, a global hub for generic drugs, has launched a new scheme to boost production of active pharmaceutical ingredients that are greatly dependent on the Chinese supply chain, according to Kant

Pharma sector needs global collaboration: Industry leaders, govt officials

The need of global collaboration in the pharma sector from research and development to drug manufacturing has never been as great as it is now amid the deadly COVID pandemic

Covid-19 prescription: Pharma players shift their focus over the counter

The pandemic pushes pharma companies to look at drugs that held promise in transitioning to over the counter segment

Domestic pharma firms working on new repurposed drug for Covid-19

Advantage over conventional plasma therapy is it will have standard antibodies

R&D for treating Covid-19 by pharmaceutical firms part of CSR activities

Activities undertaken by companies in normal course of business also part of CSR

Pharma to lose pandemic-induced pricing power in Q2 as economies reopen

Pharma companies are unlikely to sustain the healthy operating performance reported in the first quarter as they will lose the margins booked during the global lockdowns

Amazon to launch online drug sales in Bengaluru to enhance reach

Amazon.com Inc said on Friday it will launch an online pharmacy in India that will serve the city of Bengaluru, the latest move by the e-commerce giant to widen its reach in a key growth market

Hyderabad-based Biological E joins hands with J&J for Covid-19 vaccine

The vaccine candidate is in phase 1/2a clinical trials

Animal pharma Boehringer Ingelheim bets big on pet care segment in India

Boehringer Ingelheim plans to bring innovative products catering mainly to pets and poultry segment in India, as it expects these verticals to grow in a robust manner over the next few years

China to add 56 drugs to price-slashing bulk-buy programme

China added 56 medicines, including some global blockbuster drugs, to its state bidding programme aimed at procuring key treatments at big discounts in return for offering large-volume state contracts

Pharma firms commit 815,000 doses of remdesivir supply in August

Centre steps up efforts to ramp up production of antiviral drug

Pfizer profit before tax down marginally to Rs 173 crore in June quarter

Revenue stood at Rs 514.89 crore against Rs 544.40 crore for the same period a year ago

World Coronavirus Dispatch: Company insiders make $1 bn in rush for vaccine

UK to quarantine those returning from Spain, Aussi cops win halt to Black Lives Matter stir, Africa's Development Bank approves grants and other pandemic-related news across the globe

Sun Pharma's arm Taro Pharma resolves all cases with US Dept of Justice

Sun Pharma said its American arm Taro Pharmaceutical has resolved all cases involving multi-year investigations by US Department of Justice into the country's generic pharmaceutical industry

US to pay Pfizer, BioNTech $1.95 bn for 100 mn Covid-19 vaccine doses

The companies will not receive any money from the government unless their vaccine succeeds in large clinical trials

Cipla, Amgen settle case involving generic cinacalcet hydrochloride tablets

Drug major Cipla said it has reached settlement with Amgen Inc on pending litigation involving generic cinacalcet hydrochloride tablets

Pharma firms face tough Q1 as sales see sharp drop on Q4 channel stocking

Analysts estimate sequential decline of 18-26% during the quarter

Lupin recalls diabetes treatment drug Metformin Hydrochloride in US

Drug major Lupin Ltd on Wednesday said it is voluntarily recalling its diabetes treatment drug Metformin Hydrochloride extended-release tablets in the US market

Pharma SMEs will overcome short-term disruptions: CRISIL SME Tracker

Short-term disruptions include high input costs and various operational challenges.